Back to ENVESTNET ASSET MANAGEMENT INC ENVESTNET ASSET MANAGEMENT INC

CYTKCYTK
Showing 8 of 26 quarters

Position history for ENVESTNET ASSET MANAGEMENT INCENVESTNET ASSET MANAGEMENT INC's holdings in CYTOKINETICS INC

ENVESTNET ASSET MANAGEMENT INC holds 88,521 shares of CYTK (CYTOKINETICS INC), worth $7.5M as of 2026-Q2. The position was increased (+156.3% shares). CYTK represents 0.0% of ENVESTNET ASSET MANAGEMENT INC's portfolio.

Current Value

$7.5M

Current Shares

88,521

Total Value Change

+$5.8M

Total Shares Change

+55,454

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
88,521
+156.3%
$7.5M0.0%$85.19
44
2026-Q1
Decreased
34,537
-45.0%
$2.3M0.0%$60.72
0
2025-Q4
Increased
62,733
+6.2%
$4M0.0%$61.37
28
2025-Q3
Increased
59,068
+100.5%
$3.2M0.0%$53.89
43
2025-Q2
Increased
29,467
+21.2%
$973,5900.0%$33.16
30
2025-Q1
Decreased
24,321
-8.1%
$977,4610.0%$43.19
0
2024-Q4
Decreased
26,455
-20.0%
$1.2M0.0%$47.15
0
2024-Q3
Increased
33,067
+8.0%
$1.7M0.0%$52.34
28

Other major holders of CYTK: BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc., BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used